Vaccin mot influensa Injektionsvätska, suspension, förfylld spruta
Country: Շվեդիա
language: շվեդերեն
source: Läkemedelsverket (Medical Products Agency)
documentation_request_send
active_ingredient:
influensavirus A/California/7/2009 (H1N1)pdm09-deriverad stam (NYMC X-179A), spjälkat virus, inaktiverat; influensavirus A/Texas/50/2012 (H3N2)-deriverad stam (NYMC X-223A), spjälkat virus, inaktiverat; influensavirus B/Massachusetts/2/2012, spjälkat virus, inaktiverat
MAH:
Sanofi Pasteur MSD Belgium
ATC_code:
J07BB02
INN:
the influenza virus A/California/7/2009 (H1N1)pdm09-derived strain (NYMC X-179A), spjälkat virus, inactivated; influenza virus, A/Texas/50/2012 (H3N2)-derived strain (NYMC X-223A), spjälkat virus, inactivated; influenza virus B/Massachusetts/2/2012, spjälkat virus, inactivated
pharmaceutical_form:
Injektionsvätska, suspension, förfylld spruta
composition:
influensavirus A/California/7/2009 (H1N1)pdm09-deriverad stam (NYMC X-179A), spjälkat virus, inaktiverat 15 mikrog Aktiv substans; influensavirus B/Massachusetts/2/2012, spjälkat virus, inaktiverat 15 mikrog Aktiv substans; influensavirus A/Texas/50/2012 (H3N2)-deriverad stam (NYMC X-223A), spjälkat virus, inaktiverat 15 mikrog Aktiv substans
prescription_type:
Receptbelagt
therapeutic_area:
spjälkat virus eller ytantigen
authorization_status:
Avregistrerad
authorization_date:
1998-04-17
